본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
The mystique of epigenetic regulation: the remarkable case of a human noncoding RNA, nc886 Lee Yong Sun
(Department of Cancer Biomedical Science)

Lee Yeon Su
(Rare & Pediatric Cancer Branch)
. The mystique of epigenetic regulation: the remarkable case of a human noncoding RNA, nc886. EPIGENOMICS. 2024-10-28; 2024; 16(21-22):1389~1405. IF 3 (2023)
Associations Between Obesity and Risk of Thyroid Cancer: A Meta-Analysis of Cohort Studies Myung, Seung-Kwon
(Department of Cancer AI and Digital Health)

Urfa Khairatun HISAN
(Department of Cancer Control and Population Health)
. Associations Between Obesity and Risk of Thyroid Cancer: A Meta-Analysis of Cohort Studies. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL. 2024-10-26; 2024; :~. IF 2 (2023)
Cohort Profile: The Registry-based Epidemiological Study of Cancer in Fire Unit and Emergency Officers (RESCUE) cohort Jun Jae Kwan
(Cancer Information & Education Center)

Jeong Won Jeong
(Cancer Information & Education Center)
. Cohort Profile: The Registry-based Epidemiological Study of Cancer in Fire Unit and Emergency Officers (RESCUE) cohort. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2024-10-25; 2024; 53(6):dyae143~. IF 6.4 (2023)
Factors associated with COVID-19 infection in pregnant women: Focusing on maternal anxiety
()

Jeong Won Jeong
(Cancer Information & Education Center)
. Factors associated with COVID-19 infection in pregnant women: Focusing on maternal anxiety. PLOS ONE. 2024-10-24; 2024; 19(10):e0312300~. IF 2.9 (2023)
Comparison of survival outcomes and safety between early and late initiation of niraparib maintenance in newly diagnosed advanced epithelial ovarian cancer LIM MYONG CHEOL
(Department of Obstetrics and Gynecology)

Kim Ji Hyun
(Department of Obstetrics and Gynecology)
. Comparison of survival outcomes and safety between early and late initiation of niraparib maintenance in newly diagnosed advanced epithelial ovarian cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2024-10-23; 2024; :~. IF 4.5 (2023)
Prognostic value of electronic health records-based frailty measures for all-cause mortality in older patients with non-small cell lung cancer Cho, Hyunsoon
(Department of Cancer AI and Digital Health)

Tu Minh Thao
(Department of Cancer AI and Digital Health)
. Prognostic value of electronic health records-based frailty measures for all-cause mortality in older patients with non-small cell lung cancer. JOURNAL OF GERIATRIC ONCOLOGY. 2024-10-23; 2024; :102130~. IF 3 (2023)
The multifaceted role of epithelial membrane protein 2 in cancer: from biomarker to therapeutic target Lee Ho
(Department of Cancer Biomedical Science)

Jang Ji Yun
(Cancer Molecular Biology Branch)
. The multifaceted role of epithelial membrane protein 2 in cancer: from biomarker to therapeutic target. BIOMOLECULES & THERAPEUTICS. 2024-10-21; 2024; 32(6):697~707. IF 3 (2023)
Comparative analysis of single versus tandem autologous stem cell transplantation in patients with multiple myeloma in Korea: the KMM2102 study Hyeon-Seok Eom
(Center for Hematologic Malignancy)

Jung Jong Heon
(Rare & Pediatric Cancer Branch)
. Comparative analysis of single versus tandem autologous stem cell transplantation in patients with multiple myeloma in Korea: the KMM2102 study. SCIENTIFIC REPORTS. 2024-10-17; 2024; 14:24325~. IF 3.8 (2023)
Impact of graphical display on the intention to undergo risk-reducing salpingo-oophorectomy and mastectomy in individuals positive for BRCA pathogenic variant Sun-Young Kong
(Targeted Therapy Branch)

Choi Yoon Jung
(Department of Cancer Control and Population Health)
. Impact of graphical display on the intention to undergo risk-reducing salpingo-oophorectomy and mastectomy in individuals positive for BRCA pathogenic variant. SCIENTIFIC REPORTS. 2024-10-16; 2024; 14:24281~. IF 3.8 (2023)
Detailed characterization of combination treatment with MET inhibitor plus EGFR inhibitor in EGFR-mutant and MET-amplified non-small cell lung cancer Lee Young Joo
(Targeted Therapy Branch)

Lee Young Joo
(Targeted Therapy Branch)
. Detailed characterization of combination treatment with MET inhibitor plus EGFR inhibitor in EGFR-mutant and MET-amplified non-small cell lung cancer. TRANSLATIONAL LUNG CANCER RESEARCH. 2024-10-11; 2024; 13(10):~. IF 4 (2023)
First page Prev paging 11 12 13 14 15 16 17 18 19 20 next paging last page